Dentium CO., LTD (KRX:145720)

Market Cap	395.84B
Revenue (ttm)	356.03B
Net Income (ttm)	42.11B
Shares Out	8.62M
EPS (ttm)	4,882.41
PE Ratio	9.40
Forward PE	8.79
Dividend	600.00 (1.28%)
Ex-Dividend Date	Dec 27, 2024

Volume	34,746
Average Volume	40,443
Open	45,950
Previous Close	45,900
Day's Range	45,850 - 47,150
52-Week Range	43,100 - 85,500
Beta	0.83
RSI	48.74
Earnings Date	Mar 12, 2026

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2024, Dentium CO., LTD's revenue was 407.81 billion, an increase of 3.72% compared to the previous year's 393.19 billion. Earnings were 72.71 billion, a decrease of -24.67%.